BPA Call 75F40119A10019-75F40124F19040

Award Date 7/19/24
Potential Completion Date 9/28/29
Potential Value $2.7M
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
Westlake, MD 20817, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $481,237.49 contract award to International Business Machines Corporation (IBM) by the Food and Drug Administration (FDA) for TESTING DATA STANDARDS services. The contract is a Delivery Order under a Time and Materials pricing type, with a period of performance through September 14, 2017. There is no set-aside designation for this award. IBM, a major federal IT contractor, provides a wide range of hardware, software, cloud, AI, and consulting services to the U.S. government. This...
This federal contract award is for "Data Management and Data Quality - BIMO" services, with a ceiling value of $349,912.53. The contract was awarded by the Food and Drug Administration (FDA) to the prime contractor, International Business Machines Corporation (IBM), on August 25, 2022. The contract has a period of performance ending on September 27, 2023 and is a BPA Call under IBM's Regulatory Review Support Services Master BPA with the FDA. The contract is not set aside for any...
This federal contract award is for STATISTICAL PROGRAMMING SUPPORT SERVICES, provided by the prime contractor International Business Machines Corporation (IBM) to the Food and Drug Administration (FDA), a civilian agency. The $3,030,550.89 contract is a BPA (Blanket Purchase Agreement) call order under a larger Regulatory Review Support Services BPA. The contract was awarded on September 3, 2020 and has a completion date of September 15, 2023. There is no set-aside designation for this award. In...
This $7,464,141.78 contract was awarded by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) to adapt to evolving HL7 standards and ensure continuity of operations as well as enabling enhancements at the FDA. The contract is a Blanket Purchase Agreement (BPA) call and utilizes a labor hours pricing type. As the prime contractor, IBM has engaged several subcontractors, including Accenture Federal Services, Eclaro International, Eight Eleven Group, Medstar...
This federal contract award, valued at $14,672,586.36, was issued by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) for "Improvements in Pharmaceutical Quality/Chemistry, Manufacturing, and Control (PQ/CMC) Data Standards for Regulatory Submissions, Review and Analysis." The contract is a Blanket Purchase Agreement (BPA) call under the Regulatory Review Support Services BPA, which enables the FDA to efficiently procure IBM's technology...
This is a federal contract award to International Business Machines Corporation (IBM) from the Food and Drug Administration (FDA), a civilian agency. The contract is for a Regulatory Review Task Order for Year 2 Analysis Standards for Clinical Study Data, with a ceiling value of $366,897.03. The contract is a Delivery Order with a Labor Hours pricing type and an ultimate completion date of June 30, 2017. This award is not associated with a set-aside designation. IBM is the prime contractor,...
This is a firm fixed price contract awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, to International Business Machines Corporation (IBM) for $920,775.08. The contract, which is a Blanket Purchase Agreement (BPA) call, is for "REAL WORLD DATA - DATA STANDARDS FOR SUBMISSION TO FDA". IBM has utilized two subcontractors, Pinnacle 21, LLC and Gevity Consulting Inc., to provide computer programming services in...
This is a federal contract award to International Business Machines Corporation (IBM) by the Food and Drug Administration (FDA), a civilian agency, for Regulatory Review Support Services. The contract has a ceiling value of $5,794,062.73 and a completion date of September 28, 2023. It is a Blanket Purchase Agreement (BPA) call, using a Labor Hours pricing type. The contract does not have a set-aside designation. IBM is the prime contractor and has not disclosed any major subcontractors. This...
This is a BPA Call contract awarded by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) for DATA STANDARDS SUPPORT services. The contract has a ceiling value of $379,304.66 and runs through May 5, 2021. The contract is a task order under a larger Regulatory Review Support Services Blanket Purchase Agreement (BPA) with the FDA. IBM, a major federal contractor, has been awarded this contract to provide data standards support services. As a...
This $691,911.16 firm fixed-price contract was awarded by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) to provide support for data quality services. The contract is a call against IBM's Regulatory Review Support Services Blanket Purchase Agreement (BPA) with the FDA. The contract covers subject matter expertise for the development of data quality checks for incoming study data submissions. There is no set-aside designation for this award. IBM is the...

This federal contract award is for DATA STANDARDS TESTING AND IMPLEMENTATION services, with a ceiling value of $2,737,337.22. The contract was awarded to the prime contractor, International Business Machines Corporation (IBM), by the Food and Drug Administration (FDA), a civilian agency. The contract does not have a set-aside designation.

The contract is a BPA (Blanket Purchase Agreement) call under the Regulatory Review Support Services master BPA. This indicates that the services being provided are in support of the FDA's regulatory review processes. As a leading technology company, IBM has significant experience supporting federal agencies like the FDA with IT solutions, data management, and enterprise software. The long-term nature of the contract, with a completion date of September 28, 2029, suggests the criticality of the data standards work to the FDA's ongoing operations.

Generated 8/6/24, 11:00 AM